China’s ambitious effort to vaccinate 560 million people 40% of its population by the end of June is running into a supply shortage, forcing health authorities to extend the intervals between two doses, and leaving some people unable to book their second shots. The supply bottleneck comes as China’s vaccination roll out accelerates to nearly 5 million doses a day, the fastest in the world, though the proportion of its vast population covered still lags the U.S., Israel and other leading inoculating nations. While China gets its vaccine supply from domestic manufacturers, thus giving it more control than most countries which are struggling to secure doses, the accelerated pace is pushing the limits of what its homegrown makers can churn out, said people familiar with the matter.
(NOEL CELIS / AFP / FILE PHOTO)
Vaccine Expert Panel (VEP) Head Dr. Nina Gloriani, during the Laging Handa Public Briefing on Wednesday, April 7, confirmed that a recommendation has been made for the use of the said vaccine for the elderly.
Gloriani said that the recommendation was based on their assessment showing that Sinovac’s CoronaVac only causes “mild and moderate side effects” – thus, it could be used for senior citizens.
“Maganda ang safety profile niya [Sinovac] – mild to moderate ang side effects, hindi magkakaroon ng severe COVID-19 ang matatanda (It has a good safety profile. It has mild to moderate side effects so older people are expected not to have severe COVID-19),” Gloriani said.
Alleged Chinese hand: Sri Lanka approves Sinopharm vaccine for emergency use indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Chinese-Made COVID-19 Vaccines Cause International Concern | Opinion Jianli Yang
, Founder and president, Citizen Power Initiatives for China On 3/12/21 at 8:00 AM EST
Towing a similar line, Chinese vaccines against COVID-19 are proving ineffective.
No one thought that the inferior quality of Chinese vaccines would end people s lives.
Indonesian nurse Erny Kusuma Sukma Dewi died soon after she was given a dose of Beijing-based Sinovac Biotech s CoronaVac vaccine.
According to the National Union of Indonesian Nurses, 33-year-old Dewi contracted COVID-19 soon after she took a Chinese vaccine. Following fever, difficulty breathing and coughing she died.
Earlier this year, a Peruvian volunteer who took a trial of a Chinese vaccine died from COVID-19-related pneumonia. In December 2020, Peru s government suspended Sinopharm s COVID-19 vaccine because of a serious adverse event that occurred with a volunteer.
Chinese-Made COVID-19 Vaccines Cause International Concern msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.